Kreon

Pancreatin, the active ingredient in Kreon, is a pancreatic enzyme replacement presented as enteric‑coated capsules for oral use. It provides exogenous lipase, amylase and protease to aid digestion in patients with exocrine pancreatic insufficiency, cystic fibrosis or chronic pancreatitis.

GNH USA supplies Kreon as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Kreon is a pancreatic enzyme replacement that addresses digestive insufficiency in several disease groups.

Exocrine pancreatic insufficiency: improves digestion of fats, proteins and carbohydrates, reducing steatorrhea and malabsorption. Cystic fibrosis: supplements deficient pancreatic enzymes, supporting nutritional status and growth. Chronic pancreatitis: provides necessary digestive enzymes to alleviate maldigestion and related symptoms.

Kreon may cause a range of adverse reactions, most of which are mild and transient.

Common Side Effects: - Abdominal discomfort or pain - Flatulence or bloating - Diarrhea or loose stools - Nausea or mild vomiting - Constipation - Oily or fatty stools

Serious or Rare Side Effects: - Allergic reactions such as rash, itching or anaphylaxis - Intestinal obstruction or blockage - Severe abdominal pain - Fecal incontinence - Pancreatitis exacerbation - Hypersensitivity leading to respiratory distress

Before initiating Kreon, consider the following precautions.

Dose titration: adjust based on clinical response and stool fat content. Medical supervision: use under physician guidance, especially in patients with diabetes. Allergy assessment: avoid if known hypersensitivity to porcine‑derived products. Concurrent acid suppression: proton pump inhibitors may reduce efficacy; monitor. Pregnancy and lactation: safety not established; weigh benefits versus potential risks. Store at below 25°C: keep in the original pack, protect from moisture.

Kreon can interact with other medications that affect gastric pH or gastrointestinal function.

Major Interactions (Avoid): - Proton pump inhibitors: may reduce enzyme activation in the duodenum. - Antacids containing aluminum or magnesium: can bind enzymes and lower effectiveness. - Orlistat: may interfere with fat digestion and enzyme activity.

Moderate Interactions (Monitor Closely): - Antibiotics altering gut flora: may affect enzyme activity. - Diabetes medications: enhanced carbohydrate digestion may impact glucose control. - Corticosteroids: may increase risk of gastrointestinal side effects.